Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 2 |
2022 | 2 |
2023 | 3 |
2024 | 0 |
PubMed for Bookshelf ID: 5506746
7 results
Results by year
Filters applied: . Clear all
Page 1
Belzutifan in adults with VHL-associated central nervous system hemangioblastoma: a single-center experience.
J Neurooncol. 2023 Aug;164(1):239-247. doi: 10.1007/s11060-023-04395-3. Epub 2023 Jul 14.
J Neurooncol. 2023.
PMID: 37450072
von-Hippel Lindau and Hypoxia-Inducible Factor at the Center of Renal Cell Carcinoma Biology.
Shirole NH, Kaelin WG Jr.
Shirole NH, et al.
Hematol Oncol Clin North Am. 2023 Oct;37(5):809-825. doi: 10.1016/j.hoc.2023.04.011. Epub 2023 Jun 1.
Hematol Oncol Clin North Am. 2023.
PMID: 37270382
Review.
Item in Clipboard
Development of drugs targeting hypoxia-inducible factor against tumor cells with VHL mutation: Story of 127 years.
Takamori H, Yamasaki T, Kitadai R, Minamishima YA, Nakamura E.
Takamori H, et al.
Cancer Sci. 2023 Apr;114(4):1208-1217. doi: 10.1111/cas.15728. Epub 2023 Jan 31.
Cancer Sci. 2023.
PMID: 36650918
Free PMC article.
Review.
Item in Clipboard
First clinical experience with belzutifan in von Hippel-Lindau disease associated CNS hemangioblastoma.
Dhawan A, Peereboom DM, Stevens GH.
Dhawan A, et al.
CNS Oncol. 2022 Jul 12;11(3):CNS91. doi: 10.2217/cns-2022-0008. Online ahead of print.
CNS Oncol. 2022.
PMID: 35819008
Free PMC article.
Item in Clipboard
FDA Approval Summary: Belzutifan for von Hippel-Lindau Disease-Associated Tumors.
Fallah J, Brave MH, Weinstock C, Mehta GU, Bradford D, Gittleman H, Bloomquist EW, Charlab R, Hamed SS, Miller CP, Dorff SE, Chambers WA, Mixter BD, Dinin J, Pierce WF, Ricks TK, Tang S, Donoghue M, Pazdur R, Amiri-Kordestani L, Ibrahim A, Beaver JA.
Fallah J, et al.
Clin Cancer Res. 2022 Nov 14;28(22):4843-4848. doi: 10.1158/1078-0432.CCR-22-1054.
Clin Cancer Res. 2022.
PMID: 35727604
Free PMC article.
Item in Clipboard
Belzutifan for Renal Cell Carcinoma in von Hippel-Lindau Disease.
Jonasch E, Donskov F, Iliopoulos O, Rathmell WK, Narayan VK, Maughan BL, Oudard S, Else T, Maranchie JK, Welsh SJ, Thamake S, Park EK, Perini RF, Linehan WM, Srinivasan R; MK-6482-004 Investigators.
Jonasch E, et al.
N Engl J Med. 2021 Nov 25;385(22):2036-2046. doi: 10.1056/NEJMoa2103425.
N Engl J Med. 2021.
PMID: 34818478
Free PMC article.
Clinical Trial.
Item in Clipboard
Belzutifan: First Approval.
Deeks ED.
Deeks ED.
Drugs. 2021 Nov;81(16):1921-1927. doi: 10.1007/s40265-021-01606-x.
Drugs. 2021.
PMID: 34613603
Review.
Item in Clipboard
Cite
Cite